French pipeline coating service provider EUPEC (EUPX.US) is sprinting towards a US IPO, with the fundraising amount increasing by 200% to $15 million.
French land and sea steel pipe coating solutions provider EUPEC International Group (EUPX.US) updated its plan for an IPO in the United States on Monday, significantly increasing the planned fundraising amount.
It is reported that EUPEC International Group (EUPX.US), a provider of steel pipeline coating solutions in France, updated its IPO plan to the United States on Monday, significantly increasing the planned fundraising scale. The company, headquartered in Grand-Saunt, France, currently plans to issue 3.8 million shares at a price of $4 per share, raising $15 million. Previously submitted documents showed that the company had originally planned to issue 1.3 million shares at the same price. Based on the revised trading scale, EUPEC's fundraising amount will increase by 200% compared to the original expectations, and the company's market value is expected to reach $95 million.
EUPEC focuses on providing special coating services for onshore and offshore steel pipelines in the water, oil, and natural gas industries, with services including pipeline coating, custom coating, field joint coating, and coil-to-coil solutions. The company operates a 15-hectare factory in Dunkirk and has two additional facilities in France, and has provided project support for energy giants such as TotalEnergies, Eni, Exxon Mobil Corporation, Petrobras, Shell, BP, and many large engineering contractors.
Founded in 2022, EUPEC achieved revenue of $9 million in the 12 months ending June 30, 2025. The company plans to list on the NASDAQ under the stock symbol "EUPX", with R.F. Lafferty & Co. serving as the exclusive bookrunner for the offering.
Related Articles

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.
ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


